[go: up one dir, main page]

TN2009000263A1 - Pharmaceutical preparation for the alleviation of endometriosis - Google Patents

Pharmaceutical preparation for the alleviation of endometriosis

Info

Publication number
TN2009000263A1
TN2009000263A1 TNP2009000263A TN2009000263A TN2009000263A1 TN 2009000263 A1 TN2009000263 A1 TN 2009000263A1 TN P2009000263 A TNP2009000263 A TN P2009000263A TN 2009000263 A TN2009000263 A TN 2009000263A TN 2009000263 A1 TN2009000263 A1 TN 2009000263A1
Authority
TN
Tunisia
Prior art keywords
endometriosis
pharmaceutical composition
alleviation
bone density
pharmaceutical preparation
Prior art date
Application number
TNP2009000263A
Other languages
English (en)
Inventor
Christian Seitz
Annemarie Wasserfall
Holger Zimmermann
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of TN2009000263A1 publication Critical patent/TN2009000263A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TNP2009000263A 2007-03-01 2009-06-24 Pharmaceutical preparation for the alleviation of endometriosis TN2009000263A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07004202A EP1977752A1 (fr) 2007-03-01 2007-03-01 Composition pharmaceutique destinée à réduire l'endométriose
PCT/EP2008/001451 WO2008104342A1 (fr) 2007-03-01 2008-02-23 Préparation pharmaceutique conçue pour traiter une endométriose

Publications (1)

Publication Number Publication Date
TN2009000263A1 true TN2009000263A1 (en) 2010-10-18

Family

ID=38045772

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2009000263A TN2009000263A1 (en) 2007-03-01 2009-06-24 Pharmaceutical preparation for the alleviation of endometriosis

Country Status (18)

Country Link
EP (2) EP1977752A1 (fr)
JP (1) JP2010520159A (fr)
KR (1) KR20090119829A (fr)
CN (1) CN101583364A (fr)
AU (1) AU2008221012A1 (fr)
BR (1) BRPI0806598A2 (fr)
CA (1) CA2673936A1 (fr)
CO (1) CO6190606A2 (fr)
CR (1) CR10912A (fr)
DO (1) DOP2009000171A (fr)
EA (1) EA200900829A1 (fr)
EC (1) ECSP099482A (fr)
MA (1) MA31162B1 (fr)
MX (1) MX2009007259A (fr)
NZ (1) NZ577761A (fr)
SV (1) SV2009003324A (fr)
TN (1) TN2009000263A1 (fr)
WO (1) WO2008104342A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101874806A (zh) * 2009-04-29 2010-11-03 北京本草天源药物研究院 一种地诺孕素固体制剂
CN102670519B (zh) * 2011-03-16 2014-06-11 重庆莱美药业股份有限公司 一种可快速溶出的地诺孕素口服制剂及其制备方法
CN103304619B (zh) * 2013-06-08 2015-12-02 西藏海思科药业集团股份有限公司 一种地诺孕素化合物
WO2025124422A1 (fr) * 2023-12-13 2025-06-19 长春金赛药业有限责任公司 Composition de modulation d'hormone femelle implantable sous-cutanée in situ, son procédé de préparation et son utilisation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426601A1 (de) * 1994-07-27 1996-02-01 Schering Ag Verwendung eines Kombinationsproduktes enthaltend einen kompetitiven Progesteronantagonisten und ein Gestagen zur Herstellung eines Arzneimittels zur Behandlung der Endometriose oder des Leiomyomata uteri
EP1535618A1 (fr) * 2003-11-26 2005-06-01 Schering Aktiengesellschaft Préparation pharmaceutique pour le traitement hormonal continuel sur plus de 21-28 jours comprenant deux compositions d'estrogène et/ou de progestine
MY151322A (en) * 2004-04-30 2014-05-15 Bayer Ip Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
DE102004026679A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
EP1655031A1 (fr) * 2004-10-08 2006-05-10 Schering AG Utilisation de dienogest pour contraceptives hormonelles avec cycle prolongué

Also Published As

Publication number Publication date
EP2059248A1 (fr) 2009-05-20
JP2010520159A (ja) 2010-06-10
DOP2009000171A (es) 2009-08-31
CN101583364A (zh) 2009-11-18
MA31162B1 (fr) 2010-02-01
NZ577761A (en) 2012-03-30
ECSP099482A (es) 2009-08-28
EP1977752A1 (fr) 2008-10-08
EA200900829A1 (ru) 2010-02-26
CA2673936A1 (fr) 2008-09-04
WO2008104342A1 (fr) 2008-09-04
CO6190606A2 (es) 2010-08-19
AU2008221012A1 (en) 2008-09-04
SV2009003324A (es) 2009-10-02
CR10912A (es) 2009-08-13
BRPI0806598A2 (pt) 2014-05-06
MX2009007259A (es) 2009-07-10
KR20090119829A (ko) 2009-11-20

Similar Documents

Publication Publication Date Title
EP4327888A3 (fr) Formulations orales d'analogues de cytidine et leurs procédés d'utilisation
MX2009004179A (es) Uso de valerato de estradiol o 17?-estradiol en combinacion con dienogest en una terapia oral para mantener y/o incrementar la libido femenina.
BR112012026115A2 (pt) formas de dosagem sólidas orais muito baixas para hrt
MX2009001711A (es) Formulaciones de liberacion sostenida de topiramato.
EP4327867A3 (fr) Composition pharmaceutique comprenant des dérivés de glucopyranosyldiphénylméthane, forme pharmaceutique correspondante, procédé pour leur préparation et utilisations
BRPI0415639A (pt) formas de dosagem de oxicodona de liberação controlada, oral, uma vez por dia
EA200900264A1 (ru) Композиции флибансерина и способ их приготовления
CA2683786C (fr) Utilisation du tapentadol dans le traitement de la douleur et avec une incidence reduite d'effets secondaires induits par le tapentadol
MX2011007779A (es) Formulaciones galenicas de compuestos organicos.
NZ602698A (en) Parenteral pharmaceutical form which releases aromatase inhibitor and gestagens, for the treatment of endometriosis
TN2009000263A1 (en) Pharmaceutical preparation for the alleviation of endometriosis
MX2010001243A (es) Composicion anti-inflamatoria.
UA102111C2 (uk) Фармацевтична композиція у вигляді разової пероральної дози, що містить леводопу, карбідопу і ентакапон або їх солі
EP3978027A4 (fr) Substance physiologiquement active liée à une fraction biotine, et composition pour administration orale la comprenant
MX2009010763A (es) NUEVO REGIMEN DE DROSPIRENONA/17ß-ESTRADIOL, PRODUCTO FARMACEUTICO COMBINADO Y CONJUNTO DE ELEMENTOS (KIT) PARA SU APLICACION.
MX2007005525A (es) Tratamiento terapeutico de resorcion ose acelerada.
TW200638951A (en) Solid oral pharmaceutical form for contraception
NO20091057L (no) Oral legemiddelform for prevensjon
AR070023A1 (es) Uso de gestagenos en combinacion con (6s)-5-metil-tetrahidrofolato para la terapia de la endometriosis con simultanea reduccion de los efectos colaterales terapeuticos asi como reduccion del riesgo de malformaciones congenitas al comenzar un embarazo
GB2442615A (en) Modified release compositions comprising a fluorocytidine derivative for the treatment of cancer
AR063712A1 (es) Tratamiento del dolor usando satraplatino
BR0311209A (pt) Método de produção de unidades de dosagem farmacêuticas para administração oral, uso de etonogestrel, e, tablete
MD3770G2 (ro) Metodă de profilaxie a infecţiilor respiratorii virale acute nongripale
CU20090116A7 (es) Preparación farmacéutica para reducir la endometriosis
UA101370C2 (ru) Пероральные составы, которые содержат аналоги цитидина, и способы их использования